PEN FY 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.4B+17.5% YoY

Gross Profit

$942M67.1% margin

Operating Income

$189M13.5% margin

Net Income

$178M12.7% margin

EPS (Diluted)

$4.52

Cash Flow

Operating Cash Flow

$239M

Free Cash Flow

$175M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$399M

Stockholders' Equity

$1.4B

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.2B	+17.5%
Gross Profit	$942M	$755M	+24.8%
Operating Income	$189M	$9M	+1939.5%
Net Income	$178M	$14M	+1168.1%